Therapeutic Fasting as a Novel Approach to Mitigate Musculoskeletal Symptoms in Breast Cancer Patients undergoing Aromatase Inhibitor Therapy: A Feasibility Study Protocol

Henriette Meyer, Daniela A. Koppold, Osaid Shaker, Laura Eden, Lisa Schiffmann, Stefan Konigorski, Holger Cramer, Kyung-Eun Anna Choi, Hermann Einsele, Marcela Winkler, Claudia Löffler

Integrative Cancer Therapies

Published online on March 10, 2026

Abstract

Integrative Cancer Therapies, Volume 25, January-December 2026.
Introduction:Aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) or aromatase inhibitor-induced arthralgia (AIA), common side effects of long-term adjuvant endocrine therapy for breast cancer patients, can significantly affect quality of life. ...